Vitamin D3 and omega-3 fatty acids not helpful in reducing risk of frailty

Written By :  Dr. Kamal Kant Kohli
Published On 2022-12-10 14:30 GMT   |   Update On 2022-12-12 11:24 GMT
Advertisement

Frailty is defined as reduced physiological reserve and ability to cope with acute stresses. Up to half of adults over the age of 85 live with frailty and thus, preventative measures are greatly needed. Investigators at Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, were interested in examining whether vitamin D3 or marine omega-3 fatty acid supplementation reduced risk of frailty.

Advertisement

The researchers analyzed data from the VITamin D and OmegA-3 TriaL (VITAL), a clinical trial of more than 25,000 U.S. adults, also led by investigators from the Brigham. Participants completed questionnaires before the trial began, 6 months after its start, and annually throughout the trial's five-year duration.

Assessment of frailty included measures of physical function, cognition, mood, and general health. The investigators found that neither vitamin D3 nor omega-3-fatty acid supplementation had any effect on frailty scores during the time period.

They conclude that these results do not support routine use of vitamin D3 or omega-3 fatty acid supplements for frailty prevention in generally healthy, older adults.

"Our new findings from VITAL are in line with previous results that do not suggest a role of vitamin D3 or omega-3 supplements for most healthy, community dwelling older adults," said corresponding author Ariela Orkaby, MD, MPH, from the Division of Aging.

"We should consider deprescribing unnecessary pills, and instead promoting healthy lifestyle habits. Regular exercise and the Mediterranean diet are proven strategies for prevention of frailty and should be encouraged for all older adults."

"These new findings from VITAL are an important reminder that dietary supplements are not miracle pills or elixirs of youth," added JoAnn Manson, MD, DrPH, director of the main VITAL trial and chief of the Division of Preventive Medicine at the Brigham.

Reference:

Ariela R. Orkaby, Rimma Dushkes, Rachel Ward, et al Luc Djousse, Julie E. Buring, Min Lee, Nancy R. Cook, Meryl S. LeBoff, Olivia I. Okereke, Trisha Copeland, JoAnn E. Manson, JAMA Netw Open. 2022;5(9):e2231206. doi:10.1001/jamanetworkopen.2022.31206

Tags:    
Article Source : JAMA Network Open

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News